Navigation Links
Leading Blood Centers, LifeSource and Central Blood Bank, Spotlight a Unique Donor Population During National Hereditary Hemochromatosis Awareness Month

CHICAGO, JULY 14 /PRNewswire/ -- According to America's Blood Centers, every two seconds someone is in need of blood - and during the summer season the need is even more profound. In honor of National Hereditary Hemochromatosis (HH) Awareness Month in July, two of the nation's largest independent blood centers LifeSource and Central Blood Bank are hoping to reach a unique group of people who can not only help address ongoing blood collection challenges, but also help themselves in the process.

HH is a genetic blood disorder that leads to the accumulation of iron in the liver, heart, pancreas, skin and gonads. It affects an estimated one million adults - or one in 200 - in the United States, primarily those of Northern European decent. HH is easily managed by regularly drawing blood, a process called phlebotomy, which causes the body's iron levels to return to normal. LifeSource and Central Blood Bank are using the national awareness month to raise overall awareness of the condition to encourage diagnosis and to let current HH patients know that they are able to receive phlebotomies free of charge at select locations and help others in the process.

"The vast majority of these patients - and many physicians for that matter - don't realize that with a doctor's prescription, HH patients can receive regular phlebotomy treatments free of charge," says Dr. Joseph Kiss, Medical Director for Central Blood Bank. "In the past, these individuals had their blood drawn and disposed of in their doctor's office often incurring co-pays or doctor's fees. We are urging them to visit one of our select donor centers to be treated at no cost and have the added benefit of knowing that their blood can help save people's lives."

Upon diagnosis, HH is easily managed through donation of a pint of blood on a regular basis which causes iron levels to normalize. HH patients need to rid their bodies of excess blood frequently until their iron levels have been returned to normal, and then every two to six months for the rest of the patient's life.

In December 2005, Central Blood Bank implemented a variance from the Food and Drug Administration (FDA) for the collection and distribution of blood from patients with HH. In August 2008, LifeSource also implemented the same variance. Today, LifeSource and Central Blood Bank locations in the Chicago and Pittsburgh areas are not only providing a new treatment option for HH patients who are used to paying for phlebotomy treatment at a hospital or their physician, but they are increasing the blood supply.

"With the frequency of treatment, many HH patients have often struggled with and agonized over the fact that their blood was being disposed of and not able to be put to good use," Kiss said. "After the FDA allowed the blood of HH patients to be collected and donated, we received a lot of positive feedback from the HH community."

Increasing Awareness for HH

Thousands of people are living with HH and do not even know it. LifeSource and Central Blood Bank are highlighting National HH Awareness Month to promote awareness for the disease since the condition is often misdiagnosed or undiagnosed despite its high prevalence. Patients suffering from HH often first complain of symptoms that can be misinterpreted as other common ailments such as chronic fatigue, impotence, abdominal pain, muscle aches and joint pain (primarily in the fingers, knees, hips and ankles), increased pigmentation in the skin (bronze, ashen gray), depression, disorientation, memory problems, stomach swelling, nausea, among others.

Given the prevalence of the condition and hereditary nature, specialists suggest screening to detect HH for people who have a family member who has been diagnosed or who is experiencing symptoms related to HH before it causes problems. Although the majority of patients are diagnosed after age 40, the availability of genetic testing allows diagnosis of individuals at a younger age.

Males are five times more likely than females to be diagnosed with the disease due to menstruation, pregnancy, lactation, or lower iron intake. Symptoms usually appear between ages 40 and 60 when the iron build-up in the body has already reached toxic levels, causing irreparable damage to internal organs.

"After testing positive for the HFE mutation, I was quickly diagnosed with HH," says patient Christopher Jansen. "My doctor wrote me a prescription for regular phlebotomy treatments which I began at LifeSource. With health care costs on the rise, I was surprised that I could receive these ongoing treatments for free. Almost a year later I continue to have phlebotomy done at LifeSource and I'm relieved to know my blood is going to those in need. I never would have believed that my having HH could actually help save other lives."

About LifeSource

LifeSource, Chicagoland's non-profit blood center, is the largest supplier of blood and blood products in Illinois, and one of the largest blood centers in the country. Established in 1987 through a merger of the Blood Center of Northern Illinois and the American Red Cross Blood Services-Mid-America Region, LifeSource is owned and operated by The Institute for Transfusion Medicine (ITxM(SM)).

LifeSource operates 22 conveniently-located community donor centers, two mobile unit-supported donor centers, and conducts an average of 10 mobile blood drives daily (or 100 mobile blood drives weekly). Serving patients in six northern Illinois counties, LifeSource provides a half million blood products annually to approximately 60 hospitals - including 10 Level 1 Trauma Centers - in meeting the need for patient transfusion therapy. For further information surrounding LifeSource, visit

About Central Blood Bank

Established in 1951, Central Blood Bank is a not-for-profit organization that serves the transfusion needs of Pittsburgh and surrounding area hospitals. Today it is a center for excellence in transfusion medicine and an integral partner in the delivery of health care in western Pennsylvania, northern West Virginia and eastern Ohio regions. Central Blood Bank currently employs approximately 330 dedicated employees at 28 conveniently located community locations who annually collect, test and distribute 155,000 units of whole blood to more than 40 hospitals and health care facilities in the tri-state area. Fourteen mobile teams are available daily, visiting businesses, schools, churches, and community groups to provide access to donate.

For more information surrounding Central Blood Bank, visit

About The Institute for Transfusion Medicine

Founded in 1987, The Institute for Transfusion Medicine(SM) (ITxM(SM)) is one of the nation's foremost organizations specializing in transfusion medicine and related services. Headquartered in Pittsburgh, and with offices in Chicagoland, ITxM(SM) and its experienced team offer patients and medical facilities comprehensive support, including consultation with our specialized medical staff and delivery and testing of blood products by our skilled technicians. Its two blood centers, Central Blood Bank in Pittsburgh and LifeSource in Chicago, provide nearly one million units of lifesaving blood products annually. While blood collection is a fundamental part of the organization's purpose, providing safe blood products to hospitals and, ultimately, patients in need is their primary goal.

SOURCE LifeSource; Central Blood Bank
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
(Date:2/11/2016)... Viejo, CA (PRWEB) , ... February 11, 2016 , ... ... Pro X users with customizable backdrops in the Christmas edition of the ProDrop ... of the year. Captivate audiences and invoke the spirit of Christmas using ProDrop's wintry ...
(Date:2/11/2016)... CO. (PRWEB) , ... February 11, 2016 , ... ... people have become more actively engaged in health and wellness best practices in ... importance of riding this trend. February is American Heart Month, which acts as ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... expand dental health services to the developmentally disabled in the Coachella Valley. , ... to a new facility at 71-949 Highway 111, Suite 100-B, in Rancho Mirage, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group ... associations of medical professionals throughout the country. The Guard was specifically designed to ... and procedures, employee training, regulatory updates, and compliance coaching. , In addition to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... A Worldwide Clinical Trials expert will ... Victoria Park Plaza in London , 24-25 ... and future advances for late phase research on Wednesday, 24 ... , associate director of project management at Worldwide, will focus ... regulations and standards in late phase research. ...
(Date:2/10/2016)... Feb. 10, 2016  LexisNexis® Risk Solutions, a ... announced the launch of LexisNexis Provider Performance ... helps improve and optimize the quality and efficiency ... using severity-adjusted scores. By measuring provider performance through ... to deliver better outcomes, improve the patient experience ...
(Date:2/10/2016)... Feb. 10, 2016 Mast Therapeutics, Inc. ... clinical-stage therapies for sickle cell disease and heart failure, ... of 29,090,910 units at a price to the public ... share of the Company,s common stock and one warrant ... at an exercise price of $0.42 per share. The ...
Breaking Medicine Technology: